Patents Assigned to Sense Biodetection Limited
  • Nucleic acid detection method
    Patent number: 12275991
    Abstract: The present invention relates to methods for the detection of nucleic acids of defined sequence and kits and devices for use in said methods. The methods employ restriction enzymes, polymerase and oligonucleotide primers to produce an amplification product in the presence of a target nucleic acid, which is contacted with oligonucleotide probes to produce a detector product.
    Type: Grant
    Filed: January 27, 2020
    Date of Patent: April 15, 2025
    Assignee: Sense Biodetection Limited
    Inventors: Henry John Lamble, David Lloyd, Eryk Dunski, Steven Watson
  • Heaters for medical devices
    Patent number: 12239983
    Abstract: A medical device comprising a multilayer printed circuit board (PCB) comprising a heating element on an inner layer of the PCB; a single cell electrical power source to power the heating element; and a chamber adapted to contain a liquid, at least part of said chamber being defined by a thermally conductive material configured to provide a thermal transfer interface between the chamber and the PCB.
    Type: Grant
    Filed: August 26, 2021
    Date of Patent: March 4, 2025
    Assignee: Sense Biodetection Limited
    Inventor: Ralph Lamble
  • Nucleic acid detection method
    Patent number: 11591644
    Abstract: The present invention relates to methods for the detection of nucleic acids of defined sequence and kits for use in said methods. The methods employ nicking agent(s), polymerase and oligonucleotide probes to produce probe fragments in the presence of a target nucleic acid.
    Type: Grant
    Filed: January 25, 2018
    Date of Patent: February 28, 2023
    Assignee: Sense Biodetection Limited
    Inventors: Henry John Lamble, David Lloyd, Christopher Egan
  • VIRUS DETECTION
    Publication number: 20230059514
    Abstract: The present invention is directed to kits and methods for detecting and discriminating the target pathogens Influenza A Virus and Influenza B Virus and optionally Respiratory Syncytial Virus in a sample and to devices containing said kits and for use in said methods. The invention employs restriction enzymes, polymerase and oligonucleotide primers to produce, in the presence of a target pathogen, an amplification product which is contacted with oligonucleotide probes to produce a detector species.
    Type: Application
    Filed: January 25, 2021
    Publication date: February 23, 2023
    Applicant: Sense Biodetection Limited
    Inventors: Henry John LAMBLE, David LLOYD
  • Nucleic acid detection method
    Patent number: 11390909
    Abstract: The present invention relates to methods for the detection of nucleic acids of defined sequence, and compositions and kits for use in said methods. The methods employ nicking agent(s) and a sequential series of oligonucleotide probes to produce probe fragments in the presence of a target nucleic acid.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: July 19, 2022
    Assignee: Sense Biodetection Limited
    Inventors: Henry John Lamble, Christopher Egan, David Lloyd, Eryk Dunski
  • NUCLEIC ACID DETECTION METHOD
    Publication number: 20200002756
    Abstract: The present invention relates to methods for the detection of nucleic acids of defined sequence and kits for use in said methods. The methods employ nicking agent(s), polymerase and oligonucleotide probes to produce probe fragments in the presence of a target nucleic acid.
    Type: Application
    Filed: January 25, 2018
    Publication date: January 2, 2020
    Applicant: Sense Biodetection Limited
    Inventors: Henry John Lamble, David Lloyd, Christopher Egan
  • NUCLEIC ACID DETECTION METHOD
    Publication number: 20180216157
    Abstract: The present invention relates to methods for the detection of nucleic acids of defined sequence, and compositions and kits for use in said methods. The methods employ nicking agent(s) and a sequential series of oligonucleotide probes to produce probe fragments in the presence of a target nucleic acid.
    Type: Application
    Filed: July 22, 2016
    Publication date: August 2, 2018
    Applicant: Sense Biodetection Limited
    Inventors: Henry John Lamble, Christopher Egan, David Lloyd, Eryk Dunski
  • Diagnostic test device
    Patent number: D938607
    Type: Grant
    Filed: April 1, 2020
    Date of Patent: December 14, 2021
    Assignee: SENSE BIODETECTION LIMITED
    Inventor: Ralph Lamble
  • Diagnostic test device
    Patent number: D959693
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: August 2, 2022
    Assignee: SENSE BIODETECTION LIMITED
    Inventor: Ralph Lamble